论文部分内容阅读
在21名囊性纤维化患者中进行的一项为期2周的开标记临床试验显示,由Aradigm公司开发的环丙沙星脂质体吸入剂1日1次给药可减少患者痰中绿脓杆菌的数量。这项在新西兰和澳大利亚进行的临床试验发现,受试患者在使用该吸入剂产品治疗14天后,其痰中绿脓杆菌平均减少1·43 log CFU(CF
A 21-week open-label clinical trial in 21 patients with cystic fibrosis showed that once-daily administration of ciprofloxacin liposomal inhalant developed by Aradigm reduces the amount of sputum in patients with sputum pus The number of bacilli. The clinical trial in New Zealand and Australia found that patients treated with this inhalant product had an average reduction of Pseudomonas aeruginosa in their sputum by 1.43 log CFU (CF